
Sign up to save your podcasts
Or


In this episode, I sit down with two guests who are doing something genuinely different in the world of healthcare events, and they represent two very different moments in the buyer journey.
First, Jane Bogue, SVP and Chief Growth Officer at CHIME, gives a refreshingly honest take on how to get real value from a CHIME membership so that tomorrow’s HIT buyers view you as partners. She also covers the mistakes that will guarantee you waste your investment.
Then I talk with Jeremy Gottlich, Partnerships Lead at Elion Health. Elion is a research and intelligence platform focused on AI and emerging healthcare technology. They run intimate summits built around one very specific design principle: confirmed buying intent. Only health system leaders who are actively evaluating solutions in a specific category get invited, and vendor attendance is capped tightly.
Jeremy explains why this model is genuinely different from anything else in the market and why it is resonating at a moment when so many marketing teams are questioning what they are actually getting from big events.
I recorded both of these conversations at ViVE, and together they make a compelling case for thinking about your event strategy in a more deliberate way. This episode pairs well with the previous one on making the most of major events like HIMSS and ViVE. Together, they give you a fuller picture of where to invest and what to expect in return.
Key Topics:
If you are interested in discussing this or any other topic, let's have a chat. Reach out to me directly to schedule a no-obligation discussion. This isn't a sales call, but rather an opportunity to talk through your questions and challenges.
Follow me on LinkedIn.
Subscribe to The Healthtech Marketing Show on Spotify or watch us on YouTube for more insights into marketing, AI, ABM, buyer journeys, and beyond!
Thank you to our presenting sponsor, HealthcareNOW, 24/7 expert shows, interviews, and podcasts, powering healthcare leaders with innovation, policy, and strategy insights.
By Adam Turinas5
88 ratings
In this episode, I sit down with two guests who are doing something genuinely different in the world of healthcare events, and they represent two very different moments in the buyer journey.
First, Jane Bogue, SVP and Chief Growth Officer at CHIME, gives a refreshingly honest take on how to get real value from a CHIME membership so that tomorrow’s HIT buyers view you as partners. She also covers the mistakes that will guarantee you waste your investment.
Then I talk with Jeremy Gottlich, Partnerships Lead at Elion Health. Elion is a research and intelligence platform focused on AI and emerging healthcare technology. They run intimate summits built around one very specific design principle: confirmed buying intent. Only health system leaders who are actively evaluating solutions in a specific category get invited, and vendor attendance is capped tightly.
Jeremy explains why this model is genuinely different from anything else in the market and why it is resonating at a moment when so many marketing teams are questioning what they are actually getting from big events.
I recorded both of these conversations at ViVE, and together they make a compelling case for thinking about your event strategy in a more deliberate way. This episode pairs well with the previous one on making the most of major events like HIMSS and ViVE. Together, they give you a fuller picture of where to invest and what to expect in return.
Key Topics:
If you are interested in discussing this or any other topic, let's have a chat. Reach out to me directly to schedule a no-obligation discussion. This isn't a sales call, but rather an opportunity to talk through your questions and challenges.
Follow me on LinkedIn.
Subscribe to The Healthtech Marketing Show on Spotify or watch us on YouTube for more insights into marketing, AI, ABM, buyer journeys, and beyond!
Thank you to our presenting sponsor, HealthcareNOW, 24/7 expert shows, interviews, and podcasts, powering healthcare leaders with innovation, policy, and strategy insights.